CNS affective disorders part 2 Flashcards

1
Q

bipolar mood disorder

  • alteration between _____ and _____
  • subtypes:
  • -bipolar 1 (full _____ episodes)
  • -bipolar 2 (_____ episodes)
  • -_____ (“moodiness” - up and down)
A
depression
mania
manic
hypomanic
cyclothymia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mania (“the high”)

  • inflated self-esteem
  • severe _____
  • excessive _____
  • racing thoughts
  • distractibility
  • activities done in excess (e.g. spending money)
  • _____ behaviors/activities
A

insomnia
talkativeness
risky

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

depression (“the low”)

  • loss of interest in activities
  • changes in _____ resulting in weight gain or loss
  • changes in _____ patterns
  • loss of energy
  • trouble concentrating or thinking
  • repeated thoughts of _____ or death
A

appetite
sleep
suicide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

bipolar disorder

  • _____
  • _____ acid: an anti-epileptic
  • _____:
  • -anticonvulsant
  • -reasonable alternative to _____
  • -mechanism unclear
  • _____
  • _____
A
lithium
valproic
carbamazepine
clonazepam
gabapentin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pharmacology of lithium

  • Li was accidentally found to have a _____ effect in patients with _____
  • -mood stabilizer, reduces both manic and depressive symptoms
  • -_____ the _____ in patients with bipolar disorder
  • -has greater activity against _____ symptoms than _____
A
calming
mania
normalizes
mood
manic
depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pharmacology of lithium
MOA: (multiple)
1. effects on _____ and _____ transport
2. effects on _____ (NTs) and _____ - receptor binding
3. effects on _____ pathways following NT - receptor binding
–suppresses the formation of _____ (inositiol triphosphate) and _____ (diaclyglycerol)
–IP3 and DAG are important in _____ neurotransmission

A
electrolyte
ion
neurotransmitters
NT
signaling
IP3
DAG
amine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
pharmacology of lithium
pharmacokinetics (oral):
-well \_\_\_\_\_\_, 95-100%
-widely distributed
--high levels in \_\_\_\_\_, \_\_\_\_\_\_ and some areas of the brain
-not \_\_\_\_\_
-half life - 24 hours
  • maintenance therapy
  • -decreases _____ behavior and reduces both the frequency and magnitude of _____
  • _____ may be required adjectively during maintenance
A
absorbed
thyroid
bone
metabolized
manic
mood swings
antidepressants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

pharmacology of lithium
pharmacokinetics:
-excreted in the _____, extensively reabsorbed
-clearance is increased in _____
-_____ competes for renal tubular reabsorption
-_____ therapeutic window
-elevated levels cause neurotoxicity and cardiotoxicity
-nausea, vomiting, diarrhea, tremor, confusion, arrhythmias, convulsions

A

urine
pregnancy
sodium
narrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

pharmacology of lithium
therapeutic effect:
-maximal response requires several _____ or _____ of treatment
–during early phase, patient requires other _____
–drug _____ when initiating treatment and at periodic intervals therafter
–initially, patients may require neuroleptics or _____

A
days
weeks
medications
monitoring
benzodiazepines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pharmacology of lithium
adverse effects:
-drowsiness, weight gain, fine hand tremor (can be controlled by B-adrenergic antagonist)
-_____- because it interferes with antidiuretic hormone, inhibiting the kidneys ability to concentrate urine (resistant to ADH)
-_____ enlargement (dysfunction rare): hypothyroidism by blocking thyroid hormone synthesis and release
-salivary gland _____

A

polyuria
thyroid
hyposecretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
pharmacology of lithium
drug interactions:
-\_\_\_\_\_
-\_\_\_\_\_ diuretics
--lithium clearance is reduced by 25%
-\_\_\_\_\_ drugs (with the exception of clozapine), produced more severe \_\_\_\_\_ syndromes when combined with lithium
-sodium chloride
A

NSAIDs
thiazide
antipsychotic
extrapyramidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

alzheimers disease

  • most common form of _____
  • worsens as it progresses, and eventually leads to death
  • it was first described by german psychiatrist and neuropathologist Alois Alzheimer in 1906
  • although the less-prevalent early-onset Alzheimers can occur much earlier
  • in 2006, there were 26.6 million sufferers worldwide. Alzheimers is predicted to affect 1 in 85 people globally by 2050
A

dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pre dementia
-executive functions of attentiveness, planning, flexibility, and abstract thinking
-impairments in semantic memory (memory of meanings, and concept relationships) can also be symptomatic of the early stages of AD
-_____
-executive function loss
-perception (_____)
executive movement loss (apraxia)

A

apathy

agnosia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

moderate alzheimers

  • recall vocabulary, which leads to frequent incorrect word substitutions (_____)
  • illusionary misidentifications and other delusional symptoms (_____)
  • urinary _____
  • _____ term memory loss
  • failure to function _____ and _____
A
paraphasias
persecution
incontinence
long
socially
professionally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

advanced disease

  • complete loss of _____
  • can often understand and return _____ signals
  • aggression, apathy and exhaustion are common
  • people with AD will ultimately not be able to perform even the simplest task without assistance
  • _____ and _____ deteriorate to the point where they are bedridden, and they lose the ability to feed themselves
  • AD is a terminal illness, with the cause of death typically being an _____ factor, such as infection of pressure ulcers or pneumonia
A
speech
emotional
muscle mass
mobility
external
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

neuropathology

  • alzheimers disease is characterized by loss of _____ in the _____ and _____ regions
  • gross atrophy of the affected regions, including degeneration of _____ and _____ lobe and parts of the frontal cortex
  • both _____ plaques and _____ tangles are clearly visible by microscopy in brains
  • plaques are _____, mostly insoluble deposits of beta-amyloid peptide and cellular material outside and around neurons
  • tangles (neurofibrillary tangles) are aggregates of the microtubule-associated protein _____
A
neurons
cerebral cortex
subcortical
temporal
parietal
amyloid
neurofibrillary
dense
Tau
17
Q

hypothesis for alzheimers

  • cholinergic hypothesis: decreased levels of production of _____
  • NMDA hypothesis: increased NMDA activity in the _____ of the cerebral hemispheres
  • Tau hypothesis: hyperphosphorylated tau begins to pair with other threads of tau. eventually, they form _____ inside nerve cell bodies
A

acetylcholine
grey matter
neurofibrillary tangles

18
Q
anti-alzheimer agents
anticholinesterase inhibitors:
-tacrine
-rivastigmine
-galantamine
-donepezil
-inhibit acetylcholinesterase enzyme
-\_\_\_\_\_ is the only approved drug for advanced AD

NMDA receptor antagonist:
-_____ (Akatinol) is a _____ NMDA receptor antagonist first used as an _____ agent. it acts on the _____ system by blocking NMDA receptors and inhibiting their overstimulation by glutamate

A
donepezil
memantine
noncompetitive
anti-influenza
glutamatergic